Lemieux Bedard

Lemieux Bédard is a specialized healthcare communications and marketing agency based in Canada, serving the pharmaceutical, biotechnology, and medical device sectors. Established in 1987, the firm offers a comprehensive range of services including strategic planning, creative development, and digital marketing. The agency is particularly recognized for its proficiency in navigating the complex Canadian regulatory landscape, including compliance with the Pharmaceutical Advertising Advisory Board (PAAB) and Advertising Standards Canada (ASC). In 2022, Lemieux Bédard was acquired by Fishawack Health, which later rebranded as Lumanity, to strengthen its global presence and Canadian market expertise. The agency continues to operate as a key partner for life science companies looking to launch or grow brands within the Canadian market.